Quote data as of 5:17 AM ET
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Stablecoin Development Corporation reported Q1 2026 operating income of $22.3 million, a turnaround from a $3.3 million operating loss in the prior year, driven by $2.5 million in staking revenue and $22.7 million in unrealized gains on its SKY token holdings.
GAAP net income was reported at $552.4 million, but this figure is dominated by non-cash warrant accounting effects, including a $5.8 billion gain and a $5.3 billion loss on warrant liabilities, which management explicitly states should be viewed separately from operating performance.
The company holds approximately 2.26 billion SKY tokens (9% of total supply) with a fair value of $160.1 million, and continues to accumulate tokens via open-market purchases and staking rewards while maintaining a small cash balance of $18.4 million.